DT Capital Partners

PE/Buy-Out · Shanghai (China)

PE/Buy-Out

Seed

Series A

Hardware

Healthcare

Sign up free to access full profile and submit your pitch.

About

DT Capital Partners is a leading Chinese private equity firm managing approximately 20 billion RMB. The firm focuses on investments across various stages in advanced manufacturing, healthcare, innovative consumer sectors, and next-generation information technology.

Investment Criteria

Other investors that have backed the same portfolio companies as DT Capital Partners. Expand any entry to see the shared portfolio companies.

• Qiming Venture Partners

  12 shared

  Shared portfolio companies

  • Ark Biosciences Inc.
  • Bytelumio Technology (Shenzhen) Co., Ltd.
  • HaiRun Movies & TV Production Co., Ltd.
  • Hangzhou INXX Fashion Co,. Ltd.
  • Hangzhou Shulan Hospital Management Co., Ltd.
  • Hesai Group
  • Hesai Photonics Technology Co., Ltd
  • Infinigence AI
  • Shanghai Laiyifen Co.,Ltd
  • Suzhou Liangyihui Network Technology Co., Ltd.
  • Zhangjiagang Onechip Bio-Technology Co.,Ltd.
  • Zhejiang Nurotron Biotechnology Co., Ltd.
• Jingwei Venture Capital (Beijing) Investment Management Consulting Co., Ltd.

  10 shared

  Shared portfolio companies

  • Adlai Nortye Biopharma Co., Ltd.
  • BabyTree Group
  • Beijing Biostar Pharmaceuticals Co., Ltd.
  • Beijing DS365 Technology Development Co., Ltd.
  • Focus Media Holding Ltd.
  • Infinigence AI
  • Jiangxi Borayer Biotechnology Co., Ltd.
  • OlymTech, Corp.
  • Shanghai Yizhi Wenhua Co., Ltd.
  • Zhangjiagang Onechip Bio-Technology Co.,Ltd.
• CICC Capital Management Co., Ltd.

  8 shared

  Shared portfolio companies

  • Beijing CytoNiche Biotechnology Co., Ltd.
  • Chongqing TCRCure Biotechnology Co., Ltd.
  • Hangzhou INXX Fashion Co,. Ltd.
  • MicuRx Pharmaceuticals, Inc.
  • Shanghai CardiMED Medical Treatment Technology Co., Ltd.
  • Shanghai Shouqianba Internet Technology Co., Ltd.
  • Singlera Genomics Inc.
  • Suzhou Newmat Nanotechnology Co., Ltd.
• Legend Capital

  8 shared

  Shared portfolio companies

  • Beijing Weisai Shidai Sports Technology Co., Ltd.
  • Dexter Studios Co.,Ltd.
  • Ganzhou Hemay Pharmaceutical Co., Ltd.
  • Hangzhou INXX Fashion Co,. Ltd.
  • Infinigence AI
  • MicuRx Pharmaceuticals, Inc.
  • Nuanwa Technology (Wuxi) Co Ltd.
  • Suzhou Liangyihui Network Technology Co., Ltd.
• HongShan

  7 shared

  Shared portfolio companies

  • Beijing BitIntelligence Information Technology Co., Ltd.
  • Beijing Yijin Park Network Technology Co., Ltd.
  • Beijing Yiouwangmeng Technology Co., Ltd.
  • Guangdong Youmai Information Communication Co., Ltd.
  • Infinigence AI
  • Linkerbot (Beijing) Technology Co., Ltd
  • Nuanwa Technology (Wuxi) Co Ltd.
• Yunqi Partners

  7 shared

  Shared portfolio companies

  • Aolin Technology (China) Co., Ltd.
  • Bailian AI
  • CargoGM
  • FOF Weekly
  • OlymTech, Corp.
  • Suzhou Zhenli New Materials Technology Co., Ltd.
  • Worldwide Logistics Group
• Beijing CGP Investment Co, Ltd.

  6 shared

  Shared portfolio companies

  • Beijing SOJO Electric Co., Ltd.
  • Eternal Material Technology Co., Ltd.
  • Houpu Clean Energy Group Co., Ltd.
  • Porton Pharma Solutions Ltd.
  • Shenzhen Jianyi Decoration Group Co., Ltd.
  • Sichuan Hebang Biotechnology Corporation Limited
• Meridian Capital Management Co., Ltd.

  6 shared

  Shared portfolio companies

  • Beijing Tmeng Network Technology Co., Ltd.
  • Beijing Yizhong Shenhuo Culture Communication Co., Ltd.
  • Focus Media Holding Ltd.
  • FOF Weekly
  • iYunbao
  • Jiangsu 1hlx Travel Net Technology Co.,LTD
• SIG Ventures​

  6 shared

  Shared portfolio companies

  • 51 Auto Limited
  • BabyTree Group
  • BETA Technology Limited
  • Hangzhou Youpeng Network Technology Co., Ltd.
  • Xinyongbao Financial Information Services (Beijing) Co., Ltd.
  • Yunding Network Technology (Beijing)Co.,LTD.
• 5Y Capital (Morningside Venture Capital)

  5 shared

  Shared portfolio companies

  • Ark Biosciences Inc.
  • DataSimba
  • Hangzhou Bizhi Technology Co., Ltd.
  • MicuRx Pharmaceuticals, Inc.
  • Shanghai Ark Biopharmaceutical Co., Ltd.